Pfizer’s stock sinks after company cuts outlook on lower demand for COVID treatments

Pfizer and biotech drug maker shares fell after Pfizer slashed its full-year earnings outlook due to a drop in demand for COVID pills and more.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.